Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects : a Pilot Double Blind, Placebo-controlled Randomized Trial on Efficacy and Safety (NEURITES) Study

NCT01847924 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT01847924
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01847924 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects : a Pilot Double Blind, Placebo-controlled Randomized Trial on Efficacy and Safety (NEURITES) Study
Lead sponsor
National University Hospital, Singapore
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2013
Completion date
April 30, 2018
Enrollment
103 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment